[EN] NOVEL COMPOUNDS AND THEIR USE IN THERAPY<br/>[FR] NOUVEAUX COMPOSÉS ET LEUR UTILISATION EN THÉRAPIE
申请人:IMP INNOVATIONS LTD
公开号:WO2013083991A1
公开(公告)日:2013-06-13
The invention provides compounds which inhibit N-myristoyltransferase and are selective for protozoal N-myristoyltransferase and, consequently suitable to treat microbial infections, including viral and fungal infections, and protozoan infections such as malaria, leishmaniasis and sleeping sickness.
Discovery of high affinity inhibitors of Leishmania donovani N-myristoyltransferase
作者:Mark D. Rackham、Zhiyong Yu、James A. Brannigan、William P. Heal、Daniel Paape、K. Victoria Barker、Anthony J. Wilkinson、Deborah F. Smith、Robin J. Leatherbarrow、Edward W. Tate
DOI:10.1039/c5md00241a
日期:——
N-Myristoyltransferase (NMT) is a potential drug target in Leishmania parasites. Scaffold-hopping from published inhibitors yielded the serendipitous discovery of a chemotype selective for Leishmania donovani NMT; development led to high affinity inhibitors with excellent ligand efficiency. The bindingmode was characterised by crystallography and provides a structural rationale for selectivity.